Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis

被引：0
|
作者：
Miravalle, Augusto [2 ]
Hendin, Barry [3 ]
Vollmer, Timothy L. [2 ]
Kala, Mrinalini [1 ,3 ]
机构：
[1] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 350 West Thomas Rd, Phoenix, AZ 85013 USA
[2] Univ Colorado Hlth Sci, Dept Neurol, Aurora, CO 80045 USA
[3] Univ Arizona, Coll Med, Phoenix, AZ USA
来源：
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS | 2011年 / 3卷
关键词：
multiple sclerosis; glatiramer acetate; relapse rate;
D O I：
10.4137/CMT.S2057
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Glatiramer acetate (GA; Copaxone (R)) is a heterogeneous polymer of four amino acids. It is one of the therapies approved by the Food and Drug Administration in 1996 for treatment of relapsing remitting multiple sclerosis (RRMS). GA reduces the relapse rate for RRMS, and has a good safety profile and moderate efficacy. Preclinical and clinical studies reveal that GA plays a role in modulating the cells of the immune system as well as in neuroprotection. In this article, we review the role of GA in reducing the frequency of relapses in MS, as well as its efficacy, safety, and current place in therapy.
引用
收藏
页码：151 / 158
页数：8
相关论文
共 50 条
  • [31] Mechanism of action of glatiramer acetate in treatment of multiple sclerosis
    Martin S. Weber
    Reinhard Hohlfeld
    Scott S. Zamvil
    Neurotherapeutics, 2007, 4 : 647 - 653
  • [32] Multiple sclerosis:: modulation of apoptosis susceptibility by glatiramer acetate
    Aktas, O
    Ari, N
    Rieks, M
    Hoffmann, V
    Schimrigk, S
    Przuntek, H
    Pöhlau, D
    ACTA NEUROLOGICA SCANDINAVICA, 2001, 104 (05): : 266 - 270
  • [33] The membrane stabilizing effect of glatiramer acetate in multiple sclerosis
    Kravtsov, Yu. I.
    Kicherova, O. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (03) : 69 - 71
  • [34] Does glatiramer acetate provoke hepatitis in multiple sclerosis?
    Sinagra, Emanuele
    Raimondo, Dario
    Cottone, Salvatore
    Guddo, Francesca
    Rizzo, Aroldo Gabriele
    Amvrosiadis, Georgios
    Perricone, Giovanni
    Cottone, Mario
    Madonia, Salvatore
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (02) : 266 - 268
  • [35] The mechanism of action of glatiramer acetate treatment in multiple sclerosis
    Racke, Michael K.
    Lovett-Racke, Amy E.
    Karandikar, Nitin J.
    NEUROLOGY, 2010, 74 (01) : S25 - S30
  • [36] The role of glatiramer acetate in the early treatment of multiple sclerosis
    Brandes, David W.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 329 - 336
  • [37] Multiple sclerosis: Glatiramer acetate delays symptom progression
    Richards L.
    Nature Reviews Neurology, 2009, 5 (12) : 638 - 638
  • [38] Evidence for use of glatiramer acetate in multiple sclerosis - Reply
    Munari, L
    Filippini, G
    LANCET NEUROLOGY, 2005, 4 (02): : 76 - 77
  • [39] Mechanism of action of glatiramer acetate in treatment of multiple sclerosis
    Weber, Martin S.
    Hohlfeld, Reinhard
    Zamvil, Scott S.
    NEUROTHERAPEUTICS, 2007, 4 (04) : 647 - 653
  • [40] Spasticity in multiple sclerosis and role of glatiramer acetate treatment
    Eustasio Meca-Lallana, Jose
    Hernandez-Clares, Rocio
    Carreon-Guarnizo, Ester
    BRAIN AND BEHAVIOR, 2015, 5 (09):
12345